Diagnosis and pharmacological management of small intestinal bacterial overgrowth in children with intestinal failure

Canadian Journal of Gastroenterology

Volumn 25, Issue 1, 2011, Pages 41-45

  Malik, Bushra A ^a   Xie, Yuan Y ^a   Wine, Eytan ^a   Huynh, Hien Q ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Antibiotics; Hydrogen breath test; Intestinal failure; Pediatrics; Small bowel culture; Small intestinal bacterial overgrowth

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIDIARRHEAL AGENT; CIPROFLOXACIN; COTRIMOXAZOLE; CYANOCOBALAMIN; DNA 16S; FOLIC ACID; GENTAMICIN; HISTAMINE H2 RECEPTOR ANTAGONIST; METRONIDAZOLE; NEOMYCIN; NORFLOXACIN; PLACEBO; PROBIOTIC AGENT; PROTON PUMP INHIBITOR; RIFAXIMIN; TETRACYCLINE;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ASPIRATION; BACTERIAL OVERGROWTH; CHILDHOOD DISEASE; DENATURING GRADIENT GEL ELECTROPHORESIS; DIARRHEA; DNA FINGERPRINTING; DNA SEQUENCE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; GASTROINTESTINAL ENDOSCOPY; HUMAN; HYDROGEN BREATH TEST; INTESTINE FAILURE; INTESTINE FLORA; INTESTINE INFECTION; PERSISTENT DIARRHEA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT INFECTION; REVIEW; SACCHAROMYCES BOULARDII; SENSITIVITY AND SPECIFICITY; SMALL INTESTINAL BACTERIAL OVERGROWTH; SMALL INTESTINE DISEASE; UPPER SMALL BOWEL ASPIRATION; BACTERIAL COUNT; BREATH ANALYSIS; ENTEROPATHY; MALABSORPTION; MICROBIOLOGY; SMALL INTESTINE;

BREATH TESTS; COLONY COUNT, MICROBIAL; DNA FINGERPRINTING; HUMANS; INTESTINAL DISEASES; INTESTINE, SMALL; MALABSORPTION SYNDROMES;

EID: 79952270847     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2011/604643     Document Type: Review

References (52)

1. Vanner S. The small intestinal bacterial overgrowth. Irritable bowel syndrome hypothesis: Implications for treatment. Gut 2008;57:1315-21.
2. Rana SV, Bhardwaj SB. Small intestinal bacterial overgrowth. Scand J Gastroenterol 2008;43:1030-7.
3. Carter BA, Karpen SJ. Intestinal failure-associated liver disease: Management and treatment strategies past, present, and future. Semin Liver Dis 2007;27:251-8. (Pubitemid 47301765)
4. Vanderhoof JA, Young RJ, Thompson JS. New and emerging therapies for short bowel syndrome in children. Paediatr Drugs 2003;5:525-31. (Pubitemid 37046764)
5. Goulet O, Ruemmele F. Causes and management of intestinal failure in children. Gastroenterology 2006;130(2 Suppl 1):S16-28. (Pubitemid 43208856)
6. Guglielmi FW, Regano N, Mazzuoli S, et al. Cholestasis induced by total parenteral nutrition. Clin Liver Dis 2008;12:97-110. (Pubitemid 351163139)
7. Quigley EM, Quera R, Abu-Shanab A, eds. The Enteric Flora in Intestinal Failure: Small Intestinal Bacterial Overgrowth and Gut-Derived Sepsis. Malden: Blackwell Publishing, 2008.
8. Quigley EM, Quera R. Small intestinal bacterial overgrowth: Roles of antibiotics, prebiotics, and probiotics. Gastroenterology 2006;130(2 Suppl 1):S78-90. (Pubitemid 43208864)
9. Teo M, Chung S, Chitti L, et al. Small bowel bacterial overgrowth is a common cause of chronic diarrhea. J Gastroenterol Hepatol 2004;19:904-9. (Pubitemid 39093208)
10. Nieuwenhuijs VB, van Dijk JE, Gooszen HG, Akkermans LM. Obstructive jaundice, bacterial translocation and interdigestive small-bowel motility in rats. Digestion 2000;62:255-61.
11. Reddy BS, MacFie J, Gatt M, Macfarlane-Smith L, Bitzopoulou K, Snelling AM. Commensal bacteria do translocate across the intestinal barrier in surgical patients. Clin Nutr 2007;26:208-15. (Pubitemid 46477827)
12. Malone FR, Horslen SP. Medical and surgical management of the paediatric patient with intestinal failure. Curr Treat Options Gastroenterol 2007;10:379-90. (Pubitemid 47559352)
13. Camilo E, Zimmerman J, Mason JB, et al. Folate synthesized by bacteria in the human upper small intestine is assimilated by the host. Gastroenterology 1996;110:991-8. (Pubitemid 26113736)
14. Suter PM, Golner BB, Goldin BR, Morrow FD, Russell RM. Reversal of protein-bound vitamin B12 malabsorption with antibiotics in atrophic gastritis. Gastroenterology 1991;101:1039-45.
15. Lewis SJ, Young G, Mann M, Franco S, O'Keefe SJ. Improvement in specificity of [14C] d-xylose breath test for bacterial overgrowth. Dig Dis Sci 1997;42:1587-92. (Pubitemid 27394578)
16. Ghoshal U, Ghoshal UC, Ranjan P, Naik SR, Ayyagari A. Spectrum and antibiotic sensitivity of bacteria contaminating the upper gut in patients with malabsorption syndrome from the tropics. BMC Gastroenterol 2003;24;3:9.
17. Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science 2005;308:1635-8. (Pubitemid 40807514)
18. Van Citters GW, Lin HC. Management of small intestinal bacterial overgrowth. Curr Gastroenterol Rep 2005;7:317-20. (Pubitemid 41223344)
19. Saad RJ, Chey WD. Breath tests for gastrointestinal disease: The real deal or just a lot of hot air? Gastroenterology 2007;133:1763-6. (Pubitemid 350180840)
20. Levitt MD. Production and excretion of hydrogen gas in man. N Engl J Med 1969;281:122-7.
21. Eisenmann A, Amann A, Said M, Datta B, Ledochowski M. Implementation and interpretation of hydrogen breath tests. J Breath Res 2008;2:1-9.
22. Vanner S. The lactulose breath test for diagnosing SIBO in IBS patients: Another nail in the coffin. Am J Gastroenterol 2008;103:964-5. (Pubitemid 351501119)
23. Nucera G, Gabrielli M, Lupascu A, et al. Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2005;21:1391-5.
24. Anania C, Pacifico L, Olivero G, Osborn JF, Bonaiuto E, Chiesa C. Breath tests in paediatrics. Clin Chim Acta 2008;397:1-12.
25. 2-breath testing in gastrointestinal diseases: The Rome Consensus Conference. Aliment Pharmacol Ther 2009;29(Suppl 1):1-49.
26. Bishop WP. Breath hydrogen testing for small bowel bacterial overgrowth - a lot of hot air? J Pediatr Gastroenterol Nutr 1997;25:245-6.
27. Dibaise JK, Young RJ, Vanderhoof JA. Enteric microbial flora, bacterial overgrowth, and short-bowel syndrome. Clin Gastroenterol Hepatol 2006;4:11-20. (Pubitemid 43136462)
28. Wang RF, Cao WW, Cerniglia CE. PCR detection and quantitation of predominant anaerobic bacteria in human and animal fecal samples. Appl Environ Microbiol 1996;62:1242-7. (Pubitemid 26113201)
29. Hayashi H, Sakamoto M, Benno Y. Phylogenetic analysis of the human gut microbiota using 16S rDNA clone libraries and strictly anaerobic culture-based methods. Microbiol Immunol 2002;46:535-48. (Pubitemid 34947852)
30. Walter J, Hertel C, Tannock GW, Lis CM, Munro K, Hammes WP. Detection of Lactobacillus, Pediococcus, Leuconostoc, and Weissella species in human feces by using group-specific PCR primers and denaturing gradient gel electrophoresis. Appl Environ Microbiol 2001;67:2578-85. (Pubitemid 33639729)
31. Attar A, Flourie B, Rambaud JC, Franchisseur C, Ruszniewski P, Bouhnik Y. Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: A crossover, randomized trial. Gastroenterology 1999;117:794-7. (Pubitemid 29468220)
32. Castiglione F, Rispo A, Di Girolamo E, et al. Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn's disease. Aliment Pharmacol Ther 2003;18:1107-12. (Pubitemid 38021596)
33. Church DL, Bryant RD, Sim V, Laishley EJ. Metronidazole susceptibility and the presence of hydrogenase in pathogenic bacteria. Anaerobe 1996;2:147-53. (Pubitemid 26245595)
34. Di Stefano M, Malservisi S, Veneto G, Ferrieri A, Corazza GR. Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2000;14:551-6. (Pubitemid 30240746)
35. Di Stefano M, Miceli E, Missanelli A, Mazzocchi S, Corazza GR. Absorbable vs. non-absorbable antibiotics in the treatment of small intestine bacterial overgrowth in patients with blind-loop syndrome. Aliment Pharmacol Ther 2005;21:985-92. (Pubitemid 40529732)
36. Lauritano EC, Gabrielli M, Lupascu A, et al. Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2005;22:31-5. (Pubitemid 40943872)
37. Majewski M, Reddymasu SC, Sostarich S, Foran P, McCallum RW. Efficacy of rifaximin, a nonabsorbed oral antibiotic, in the treatment of small intestinal bacterial overgrowth. Am J Med Sci 2007;333:266-70. (Pubitemid 46787954)
38. Pimentel M. Review of rifaximin as treatment for SIBO and IBS. Expert Opin Investig Drugs 2009;18:349-58.
39. Scarpellini E, Gabrielli M, Lauritano CE, et al. High dosage rifaximin for the treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2007;25:781-6. (Pubitemid 46434913)
40. Vanderhoof JA, Young RJ, Murray N, Kaufman SS. Treatment strategies for small bowel bacterial overgrowth in short bowel syndrome. J Pediatr Gastroenterol Nutr 1998;27:155-60. (Pubitemid 28354946)
41. Yang J, Lee HR, Low K, Chatterjee S, Pimentel M. Rifaximin versus other antibiotics in the primary treatment and retreatment of bacterial overgrowth in IBS. Dig Dis Sci 2008;53:169-74. (Pubitemid 350265666)
42. Weinstein MJ, Wagman GH, Oden EM, Marquez JA. Biological activity of the antibiotic components of the gentamicin complex. J Bacteriol 1967;94:789-90.
43. Bartlett AV, Torun B, Morales C, Cano F, Cruz JR. Oral gentamicin is not effective treatment for persistent diarrhea. Acta Paediatr Suppl 1992;381:149-54.
44. Wu WC, Zhao W, Li S. Small intestinal bacteria overgrowth decreases small intestinal motility in the NASH rats. World J Gastroenterol 2008;14:313-7. (Pubitemid 351314317)
45. Church DL, Laishley EJ. Reduction of metronidazole by hydrogenase from Clostridia. Anaerobe 1995;1:81-92.
46. Capron JP, Gineston JL, Herve MA, Braillon A. Metronidazole in prevention of cholestasis associated with total parenteral nutrition. Lancet 1983;1:446-7. (Pubitemid 13137378)
47. Bouhnik Y, Alain S, Attar A, et al. Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome. Am J Gastroenterol 1999;94:1327-31. (Pubitemid 29214649)
48. Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, Shetty AK. Lactobacillus sepsis associated with probiotic therapy. Paediatrics 2005;115:178-81. (Pubitemid 43046298)
49. Soondrum K, Hinds R. Management of intestinal failure. Indian J Pediatr 2006;73:913-8.
50. Tillman R, King C, Toskes P. Continued experience with the xylose breath test: Evidence that the small bowel culture as the gold standard for bacterial overgrowth may be tarnished. Gastroenterology 1981;80:A1304 (Abst).
51. Wilde J, Eiden J, Yolken R. Removal of inhibitory substances from human fecal specimens for detection of group A rotaviruses by reverse transcriptase and polymerase chain reactions. J Clin Microbiol 1990;28:1300-7. (Pubitemid 20194423)
52. Ching YA, Gura K, Modi B, Jaksic T. Paediatric intestinal failure: Nutrition, pharmacologic, and surgical approaches. Nutr Clin Pract 2007;22:653-63.